19,058

ALL Associate Newsletter - Vol. 9, No 22 - Monday, May 28, 2012
Thursday, May 24, 2012 - By Leslie Tignor

American Life League
Associate Newsletter
Volume 9, Number 22
Monday, May 28, 2012


Prayer Request
Please continue to pray for Peg Saindon (Mother and Unborn Baby Care of Fox Valley).


The Pill Kills 2012: What are you doing to promote the symposium and protests?
“[C]hallenges to our moral core must not be ignored. They must be met with bold correction or their seeds will suffocate us into chaos and extinction. If we begin to grow up in a society that condones sexual behavior that cannot reproduce life, what other result can we expect?”

Although he had President Obama’s approval of homosexual marriage in his sites, African American pastor Bishop Darryl Husband hit the nail on the head when he asked that question, condemning sexual behavior that cannot reproduce life.

Some people, however, just don’t seem to be able to connect the dots and fail to understand that intentionally sterile sex is a death knell for women, babies and society. They perish for lack of knowledge. The Pill Kills National Symposium can connect the dots for those who are in the dark about the dangers and impact of the pill.

We stand at a critical crossroads in our nation’s history today, as the government reaches its huge, domineering hand into our churches and religious institutions to tell us we must violate our consciences by paying for sterilization, birth control and abortion-causing drugs. All eyes are on us. Right now, we have a tremendous chance to impact public opinion by educating the public about the dangers of the pill.

We need your help to make 2012 the most successful campaign ever against the pill.
  
    1. Please let us know right away what you are doing locally to protest the pill.  We need the information to help us emphasize that this is a grassroots, nationwide effort. It will be used in our efforts to attract more attention to your local protests and nationwide to expose the deadly impact of the pill on women, families, communities and society.
  
     2.  Please forward our flyer/invitation (http://thepillkills.com/pdf/PK2012Invitation.pdf) to your lists to help publicize the national symposium. Those who cannot attend can view the symposium via live streaming on our website, www.thepillkills.com.

We absolutely must seize the moment! Together, we can make a huge impact in public opinion, lead souls to heaven, and save the lives of women and babies. Let’s all join hands and work harder than we have ever worked to expose the danger and chaos that lie along the path strewn with contraception. Let us know today what your plans are!


Tip of the Month – Prostaglandins
From Infant Homicides through Contraceptives
 
The category of anti-life chemicals which caused the most initially intense opposition from the pro-life movement was the prostaglandins. Prostaglandins (PGs) discussed here are: misoprostol (Cytotec) by GD Searle, prostaglandin E2 (Prostin E2) and carboprost tromethamine (Hebamate); the latter two are by Pharmacia & Upjohn. All three are available in the United States and many other countries.

Misiprostol, manufactured by GD Searle of Skokie, IL, a subsidiary of Monsanto Chemical, is approved for use in the U.S. as a cytoprotective (an agent that protects cells from noxious chemicals or other stimuli) for patients using non-steroidal anti-inflammatory drugs (NSAIDs) to treat conditions which cause inflammation, especially in the joints (e.g., arthritis). It has the potential to be abortifacient in as little as one dose and has shown that effect in clinical trials while it underwent approval as a cytoprotective as well as during trials in which it was used as a co-abortifacient along with mifepristone. It is the PG drug of choice as an adjunct to mifepristone in Europe, Latin America and North America. Amid criticism from many sides, Searle has issued statements condemning the use of misoprostol as an abortifacient, although it has taken no active role in preventing dissemination of its product for chemical abortion.  It has stated, in part:

Cytotec was discovered and developed by Searle for the prevention of ulcers in people taking arthritis medications . . . Any other use of this product constitutes its misuse. Searle strongly opposes any effort designed to approve its use either in the United States or elsewhere for use with RU 486 [mifepristone] in abortion. It is not Searle’s intention or desire to become embroiled in the abortion issue . . .

Searle’s handwringing notwithstanding, it found no problem in the same communication to justify its relabeling of the product in France as a “limited exception permitting use in this population [women of childbearing potential] in specialized hospitals only.” Those “specialized hospitals” were no less than dedicated abortion mills. As to Searle’s being “embroiled in the abortion issue,” that was a decision the company made years ago when it began selling two types of intrauterine devices (IUDs), mechanical devices which are abortifacient almost 100% of the time. Searle was also the first drug firm in the U.S. to breach the tabooed wall of making and selling OCs when it introduced Enovid on the U.S. market in 1960 after years of experimenting guinea pig style with Puerto Rican women.

PGs are the body’s most ubiquitous active biological substances and, in synthetic forms, can be used to induce labor during a complicated delivery or−in much higher doses−induce second [primarily from the 13th to 22nd weeks of gestation] and third trimester abortions. The PGs in the so-called E and F series induce the most violent uterine contractions and . . . it is not uncommon for the abortionist using PGs alone to be faced with the “dreaded complication” of a live abortion; i.e., a baby who survives the chemical ordeal.

PGs exhibit numerous side effects, many of which are potentially dangerous and life-threatening, including but not limited to: special risks to patients with asthma; hypotension; hypertension; cardiovascular, renal and/or hepatic disease; anemia; jaundice; diabetes; epilepsy; a compromised [scarred] uterus; uterine atony (loss of muscle tone); hemorrhage; incomplete abortion; vomiting; nausea; diarrhea; prostaglandin hyperthermia; headache; flushing; anxiety; chills; leg cramps; breast tenderness and many others.


News

New study links blood clot risk to NuvaRing
According to the study published on May 10, 2012, in the British Medical Journal, non-oral contraceptives, including NuvaRing, have a higher risk of blood clots than combined oral contraceptives (COCs) based on estrogens and progestins. NuvaRing, approved by the FDA in 2001, is a contraceptive that comes in the form of a vaginal ring using female hormones in an effort to prevent ovulation. Women who used a vaginal ring had a 6.5 times higher risk for developing blood clots compared to non-users of hormonal contraception. As of December 31, 2011, approximately 950 lawsuits were pending, alleging injuries sustained from NuvaRing use, including some alleged deaths, heart attacks and strokes.
http://www.timesunion.com/business/press-releases/article/New-Study-Links-Blood-Clot-Risk-to-NuvaRing-3565024.php#ixzz1vA2G8HNN


What the Pill is doing to our water supply
Even as the popularity of oral contraceptives remains high, the drugs themselves have been evolving in response to further discoveries about the human reproductive system, as well as efforts to reduce the Pill’s negative side effects. As with any major technological or medical development, particularly one embraced very quickly by a large sector of the population, it can take years, and even decades, for the full range of effects to become evident. And as demonstrated by several recent studies, many questions remain unanswered regarding the long-term and environmental effects of the hormones used in oral contraceptives, as well as other medical treatments.
http://www.zenit.org/article-34791?l=english


Law professor says flawed view of sex threatens religious freedom
A law professor at George Mason University believes that current threats to religious freedom are intrinsically connected to the modern understanding that “sexual freedom is about shaping yourself.” Helen Alvaré observed that many modern threats to religious freedom “are coming by way of a newly strong government position on human sexuality.” This view holds that sex is unrelated to procreation or the union of man and woman, but is simply about “expressing oneself” and forming one’s identity through various sexual acts, she explained.
http://www.catholicnewsagency.com/news/law-professor-says-flawed-view-of-sex-threatens-religious-freedom/


Study: Repeat abortions greatly raise breast cancer risk
A new study published in the Asian Pacific Journal of Cancer Prevention in February reported a very statistically significant increased risk of breast cancer for women with previous abortions as opposed to women who have never had one. The study, consisting of 1,351 women and led by researcher Ai-Ren Jiang, reported a statistically significant 1.52-fold elevation in risk for women with induced abortions and a “significant dose-response relationship between (the risk) for breast cancer and number of induced abortions,” meaning the risk climbed with a higher number of previous abortions.
http://www.lifenews.com/2012/05/15/study-repeat-abortions-greatly-raise-breast-cancer-risk/


Closing Thought

“Anyone who keeps close to a holy man discovers that by seeing him often, listening to his words and witnessing his exemplary behavior, he is set on fire with love of the truth, keeps away from the darkness of sin, and is inflamed by the love of divine light. . . . Seek the company of good people. If you share their company, you will also share their virtue.”

St. Bonaventure quoting St. Gregory
http://chosetherightpath.blogspot.com/2011/01/friends-to-keep-fire-lit.html




NOTE: Referral to web sites not produced by American Life League is for informational purposes only and does not constitute an endorsement of the sites' content.

Comments

* = Required Fields
    • Your Name*
    • Your Email Address*
    • Comment*
    • Enter the code*